同成医药 (837062.OC)

+ 收藏

利润表(同成医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 200,249,262.42360,125,194.02177,831,778.44535,550,337.68321,030,334.31
 营业收入(元) 200,249,262.42360,125,194.02177,831,778.44535,550,337.68321,030,334.31
二、营业总成本(元) 197,630,292.05378,796,846.02183,060,498.82430,437,711.11239,523,721.98
 营业成本(元) 178,291,401.59336,317,397.95163,906,070.17375,046,012.37215,401,833.79
 研发费用(元) 5,721,986.6711,107,350.196,212,434.1022,767,803.6412,782,842.92
 营业税金及附加(元) 1,009,969.231,845,680.96925,112.352,333,691.001,049,094.10
 销售费用(元) 836,635.472,365,143.521,279,825.883,706,469.731,937,398.96
 管理费用(元) 6,266,423.3317,376,213.296,741,087.5327,578,705.289,434,669.98
 财务费用(元) 5,503,875.769,785,060.113,995,968.79-994,970.91-1,082,117.77
  其中:利息费用(元) 6,298,944.7211,037,705.984,659,692.313,741,393.601,191,781.28
  其中:利息收入(元) 314,777.07647,277.89342,317.76948,808.12438,663.15
三、其他经营收益
 资产处置收益(元) 70,246.849,097.259,097.252,209,745.402,197,356.02
 资产减值损失(元) --8,791,442.42-7,538,170.19-483,914.73-
 信用减值损失(元) -956,217.14132,582.15-68,169.34991,713.06401,837.85
 其他收益(元) 1,344,642.871,000,502.7934,869.86534,101.01229,904.79
四、营业利润(元) 3,077,642.94-26,320,912.23-12,791,092.80108,364,271.3184,335,710.99
 加:营业外收入(元) 30.36102,317.1153,411.8926,570.4413,190.79
 减:营业外支出(元) 202,944.28692,932.51311,968.57375,162.39267,184.83
五、利润总额(元) 2,874,729.02-26,911,527.63-13,049,649.48108,015,679.3684,081,716.95
 减:所得税费用(元) -261,665.25-5,411,646.34-2,671,433.1111,354,672.7511,027,008.39
六、净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
(一)按经营持续性分类
  持续经营净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
 扣除非经常性损益后的净利润(元) 2,106,509.28-21,824,105.25-10,195,894.4994,654,328.8771,234,728.12
七、每股收益
 一、基本每股收益(元) 0.04-0.26-0.131.180.89
 二、稀释每股收益(元) 0.04-0.26-0.131.180.89
九、综合收益总额(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
 归属于母公司所有者的综合收益总额(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
公告日期 2024-08-232024-04-162023-08-282023-03-032022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院